Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients A pre-experimental prospective study at a general hospital in Indonesia
Journal Title: Sultan Qaboos University Medical Journal - Year 2018, Vol 18, Issue 1
Abstract
Objectives: This study aimed to evaluate the role of a clinical pharmacist intervention in decreasing subsequent clinical and drug-related problems (DRPs) among coronary heart disease (CHD) inpatients with at least one previous DRP. Methods: This pre-experimental study with a pre-post design was carried out from January to April 2017 among inpatients with at least one previous DRP at a general hospital in Tangerang District, Banten, Indonesia. Clinical and DRPs were documented prospectively by a clinical pharmacist, with DRPs classified using Version 6.2 of the DRP classification scheme of the Pharmaceutical Care Network Europe Foundation. The intervention consisted of a discussion of identified DRPs with physicians, patients, pharmaceutical logistics clerks, nurses and nutritionists. Following this, any subsequent clinical and DRPs were re-identified and further interventions were conducted as necessary. Results: A total of 75 inpatients were included in the study. Pre-intervention, there were 443 DRPs and 202 clinical problems. The most frequent DRPs were adverse drug reactions (52.6%), followed by drug effects (41.8%). Most DRPs were of moderate severity and would have resulted in moderate consequences had the pharmacist not intervened. The interventions resulted in a significant reduction in the number of DRPs, type of DRPs and number of clinical problems (P <0.05 each). Patients with complications were 26.047 times more likely to have no reduction or an increased number of clinical problems compared to patients without complications (P <0.05). Conclusion: Clinical pharmacist interventions were found to reduce subsequent DRPs and clinical problems among CHD patients with at least one previous DRP.
Authors and Affiliations
Vina A. Sagita, Anton Bahtiar, Retnosari Andrajati
Keywords
Related Articles
- EP ID EP22862
- DOI 10.18295/squmj.2018.18.01.013
- Views 325
- Downloads 17
Extensive Fixed Drug Eruption Due to Diclofenac
Paraparetic Variant of Guillain-Barré Syndrome in First 24 Hours of Postpartum Period: A case report
Guillain-Barré syndrome (GBS) is a heterogeneous disorder with a diverse clinical presentation ranging from weakness of certain body regions to tetraparesis with autonomic dysfunction and respiratory failure. Paraparetic...
The Controversies of Hyponatraemia in Hypothyroidism Weighing the evidence
Hyponatraemia is a common electrolyte disturbance, with moderate (serum sodium: 125–129 mmol/L) to severe (serum sodium: ≤125 mmol/L) forms of the disease occurring in 4–15% of hospitalised patients. While it is...
A Rare Presentation of Attention Defcit/Hyperactivity Disorder A recommendation to be more alert!
We report the case of a 7 year-old Omani girl with tuberous sclerosis (TS), attention defcit hyperactivity disorder (ADHD) and bipolar disorder (BD), at Sultan Qaboos University Hospital (SQUH), Oman. For a year she ha...
Keyhole Surgery of the Kidney at Sultan Qaboos University Hospital, Oman
Objectives: Percutaneous access surgery of the kidneys was introduced in Sultan Qaboos University Hospital (SQUH) in 998. We are presenting our early experience in the first 3 patients operated on over an eight ye...